Sulforaphane is anticonvulsant and improves mitochondrial function

Journal of Neurochemistry

Volumn 135, Issue 5, 2015, Pages 932-942

  Carrasco Pozo, Catalina ^a,b   Tan, Kah Ni ^a   Borges, Karin ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

epilepsy; mitochondrial respiration; Nrf2; pilocarpine; seizure; sulforaphane

Indexed keywords

ADENOSINE TRIPHOSPHATE; FLUROTHYL; PILOCARPINE; ROTENONE; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; ANTICONVULSIVE AGENT; CONVULSANT AGENT; ISOTHIOCYANIC ACID DERIVATIVE; MALONALDEHYDE; PENTETRAZOLE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SULFORAFAN; SUPEROXIDE DISMUTASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIOENERGY; CONTROLLED STUDY; ENZYME SYNTHESIS; EPILEPTIC STATE; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TONIC SEIZURE; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ELECTROSHOCK; EPILEPSY; METABOLISM; NERVE DEGENERATION; PATHOLOGY; ULTRASTRUCTURE;

ANIMALS; ANTICONVULSANTS; CONVULSANTS; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX I; ELECTROSHOCK; EPILEPSY; FLUROTHYL; HIPPOCAMPUS; ISOTHIOCYANATES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICE; MITOCHONDRIA; NERVE DEGENERATION; OXIDATIVE STRESS; PENTYLENETETRAZOLE; PILOCARPINE; SUPEROXIDE DISMUTASE;

EID: 84955239862     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13361     Document Type: Article

References (48)

1. Benson M. J., Thomas N. K., Talwar S., Hodson M. P., Lynch J. W., Woodruff T. M., and, Borges K., (2015) A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models. Neurobiol. Dis. 76, 87-97.
2. Benzie I. F., and, Strain J. J., (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 239, 70-76.
3. Birch-Machin M. A., Briggs H. L., Saborido A. A., Bindoff L. A., and, Turnbull D. M., (1994) An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem. Med. Metab. Biol. 51, 35-42.
4. Borges K., (2008) Mouse models: the ketogenic diet and polyunsaturated fatty acids. Epilepsia 8, 64-66.
5. Borges K., Gearing M., McDermott D. L., Smith A. B., Almonte A. G., Wainer B. H., and, Dingledine R., (2003) Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp. Neurol. 182, 21-34.
6. Brand M. D., and, Nicholls D. G., (2011) Assessing mitochondrial dysfunction in cells. Biochem. J. 435, 297-312.
7. Bulteau A. L., Ikeda-Saito M., and, Szweda L. I., (2003) Redox-dependent modulation of aconitase activity in intact mitochondria. Biochemistry 42, 14846-14855.
8. Carrasco-Pozo C., Mizgier M. L., Speisky H., and, Gotteland M., (2012) Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells. Chem. Biol. Interact. 195, 199-205.
9. Chen X. L., Dodd G., Thomas S., Zhang X., Wasserman M. A., Rovin B. H., and, Kunsch C., (2006) Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am. J. Physiol. 290, H1862-H1870.
10. Dingledine R., Varvel N. H., and, Dudek F. E., (2014) When and how do seizures kill neurons, and is cell death relevant to epileptogenesis? Adv. Exp. Med. Biol. 813, 109-122.
11. Dinkova-Kostova A. T., and, Abramov A. Y., (2015) The emerging role of Nrf2 in mitochondrial function. Free Radic. Biol. Med. doi: 0.1016/j.freeradbiomed.2015.04.036, in press.
12. Greco T., Shafer J., and, Fiskum G., (2011) Sulforaphane inhibits mitochondrial permeability transition and oxidative stress. Free Radic. Biol. Med. 51, 2164-2171.
13. Gusakov I. V., Sharonov B. P., Oparina T. I., and, Kambarova D. K., (1995) Effect of superoxide dismutase on convulsive seizures in rat models of epilepsy. Bull. Exp. Biol. Med. 120, 665-667.
14. Hadera M. G., Smeland O. B., McDonald T. S., Tan K. N., Sonnewald U., and, Borges K., (2014) Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy. J. Neurochem. 129, 107-119.
15. Kochanek P. M., Jackson T. C., Ferguson N. M., et al,. (2015) Emerging therapies in traumatic brain injury. Semin. Neurol. 35, 83-100.
16. Lee S., Kim J., Seo S. G., Choi B. R., Han J. S., and, Lee K. W., (2014) Sulforaphane alleviates scopolamine-induced memory impairment in mice. Pharmacol. Res. 85, 23-32.
17. Liang L. P., and, Patel M., (2004) Mitochondrial oxidative stress and increased seizure susceptibility in Sod2(-/+) mice. Free Radic. Biol. Med. 36, 542-554.
18. Liu Y., Hettinger C. L., Zhang D., Rezvani K., Wang X., and, Wang H., (2014) Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease. J. Neurochem. 129, 539-547.
19. Löscher W., (2011) Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 20, 359-368.
20. Mazzuferi M., Kumar G., Rospo C., and, Kaminski R. M., (2012) Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization. Exp. Neurol. 238, 156-167.
21. Mazzuferi M., Kumar G., van Eyll J., Danis B., Foerch P., and, Kaminski R. M., (2013) Nrf2 defense pathway: experimental evidence for its protective role in epilepsy. Ann. Neurol. 74, 560-568.
22. Melov S., Coskun P., Patel M., et al,. (1999) Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl Acad. Sci. USA 96, 846-851.
23. Milder J. B., Liang L. P., and, Patel M., (2010) Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiol. Dis. 40, 238-244.
24. Murphy M. P., (2009) How mitochondria produce reactive oxygen species. Biochem. J. 417, 1-13.
25. Neal E. G., Chaffe H., Schwartz R. H., Lawson M. S., Edwards N., Fitzsimmons G., Whitney A., and, Cross J. H., (2008) The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 7, 500-506.
26. Noyan-Ashraf M. H., Sadeghinejad Z., and, Juurlink B. H., (2005) Dietary approach to decrease aging-related CNS inflammation. Nutr. Neurosci. 8, 101-110.
27. Nulton-Persson A. C., and, Szweda L. I., (2001) Modulation of mitochondrial function by hydrogen peroxide. J. Biol. Chem. 276, 23357-23361.
28. Patel M., (2004) Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic. Biol. Med. 37, 1951-1962.
29. Perez-Pinzon M. A., Stetler R. A., and, Fiskum G., (2012) Novel mitochondrial targets for neuroprotection. J. Cereb. Blood Flow Metab. 32, 1362-1376.
30. Rogers G. W., Brand M. D., Petrosyan S., Ashok D., Elorza A. A., Ferrick D. A., and, Murphy A. N., (2011) High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS ONE 6, 25.
31. Rowley S., and, Patel M., (2013) Mitochondrial involvement and oxidative stress in temporal lobe epilepsy. Free Radic. Biol. Med. 62, 121-131.
32. Rowley S., Liang L.-P., Fulton R., Shimizu T., Day B., and, Patel M., (2015) Mitochondrial respiration deficits driven by reactive oxygen species in experimental temporal lobe epilepsy. Neurobiol. Dis. 75, 151-158.
33. Samala R., Willis S., and, Borges K., (2008) Anticonvulsant profile of a balanced ketogenic diet in acute mouse seizure models. Epilepsy Res. 81, 119-127.
34. Schmued L. C., and, Hopkins K. J., (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874, 123-130.
35. Singh K., Connors S. L., Macklin E. A., Smith K. D., Fahey J. W., Talalay P., and, Zimmerman A. W., (2014) Sulforaphane treatment of autism spectrum disorder (ASD). Proc. Natl Acad. Sci. USA 111, 15550-15555.
36. Smeland O. B., Hadera M. G., McDonald T. S., Sonnewald U., and, Borges K., (2013) Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice. J. Cereb. Blood Flow Metab. 33, 1090-1097.
37. Smith M., Wilcox K. S., and, White H. S., (2007) Discovery of antiepileptic drugs. Neurotherapeutics 4, 12-17.
38. Thimmulappa R. K., Lee H., Rangasamy T., Reddy S. P., Yamamoto M., Kensler T. W., and, Biswal S., (2006) Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Investig. 116, 984-995.
39. Thomas N. K., Willis S., Sweetman L., and, Borges K., (2012) Triheptanoin in acute mouse seizure models. Epilepsy Res. 99, 312-317.
40. Wang J., Fields J., Zhao C., Langer J., Thimmulappa R. K., Kensler T. W., Yamamoto M., Biswal S., and, Dore S., (2007) Role of Nrf2 in protection against intracerebral hemorrhage injury in mice. Free Radic. Biol. Med. 43, 408-414.
41. Wang W., Wu Y., Zhang G., Fang H., Wang H., Zang H., and, Xie T., (2014) Activation of Nrf2-ARE signal pathway protects the brain from damage induced by epileptic seizure. Brain Res. 28, 54-61.
42. White H. S., (2003) Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia 7, 2-8.
43. Whitman S. A., Long M., Wondrak G., Zheng H., and, Zhang D. D., (2013) Nrf2 modulates contractile and metabolic properties of skeletal muscle in streptozotocin-induced diabetic atrophy. Exp. Cell Res. 319, 2673-2683, doi: 10.1016/j.yexcr.2013.1007.1015.
44. Willis S., Stoll J., Sweetman L., and, Borges K., (2010) Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models. Neurobiol. Dis. 40, 565-572.
45. Zhao J., Moore A. N., Clifton G. L., and, Dash P. K., (2005) Sulforaphane enhances aquaporin-4 expression and decreases cerebral edema following traumatic brain injury. J. Neurosci. Res. 82, 499-506.
46. Zhao J., Kobori N., Aronowski J., and, Dash P. K., (2006) Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci. Lett. 393, 108-112.
47. Zhao J., Moore A. N., Redell J. B., and, Dash P. K., (2007a) Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J. Neurosci. 27, 10240-10248.
48. Zhao X., Sun G., Zhang J., Strong R., Dash P. K., Kan Y. W., Grotta J. C., and, Aronowski J., (2007b) Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke 38, 3280-3286.